Awards for “TEVA PHARMACEUTICALS USA, INC.”
25 awards on this page · sorted by amount · page 16
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| SPE2DP21F3212 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-04-06 | 2021-04-27 | 325412 | 8508113868!ADENOVIRUS TYPE 4 A |
| SPE2DP21F3207 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-04-06 | 2021-04-27 | 325412 | 8508113860!ADENOVIRUS TYPE 4 A |
| SPE2DP21F3206 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-04-06 | 2021-04-27 | 325412 | 8508113737!ADENOVIRUS TYPE 4 A |
| SPE2DP21F3205 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-04-06 | 2021-04-27 | 325412 | 8508113734!ADENOVIRUS TYPE 4 A |
| SPE2DP21F3196 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-04-06 | 2021-04-27 | 325412 | 8508113479!ADENOVIRUS TYPE 4 A |
| SPE2DP21F2057 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-02-11 | 2021-02-23 | 325412 | 8507981887!ADENOVIRUS TYPE 4 A |
| SPE2DP21F2055 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-02-11 | 2021-02-23 | 325412 | 8507981431!ADENOVIRUS TYPE 4 A |
| SPE2DP21F2051 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-02-11 | 2021-02-23 | 325412 | 8507981227!ADENOVIRUS TYPE 4 A |
| SPE2DP21F1559 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-01-14 | 2021-01-26 | 325412 | 8507913704!ADENOVIRUS TYPE 4 A |
| SPE2DP21F1547 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-01-14 | 2021-01-26 | 325412 | 8507913573!ADENOVIRUS TYPE 4 A |
| SPE2DP21F1537 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-01-14 | 2021-01-26 | 325412 | 8507913464!ADENOVIRUS TYPE 4 A |
| SPE2DP21F1007 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $271.49K | 2020-12-07 | 2020-12-15 | 325412 | 8507846499!ADENOVIRUS TYPE 4 A |
| SPE2DP21F1006 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $271.49K | 2020-12-07 | 2020-12-15 | 325412 | 8507846497!ADENOVIRUS TYPE 4 A |
| SPE2DP21F0998 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $271.49K | 2020-12-07 | 2020-12-15 | 325412 | 8507846105!ADENOVIRUS TYPE 4 A |
| SPE2DP21F0380 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $271.49K | 2020-11-03 | 2020-12-15 | 325412 | 8507773464!ADENOVIRUS TYPE 4 A |
| SPE2DP21F0379 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $271.49K | 2020-11-03 | 2020-11-17 | 325412 | 8507773463!ADENOVIRUS TYPE 4 A |
| SPE2DP21F0375 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $271.49K | 2020-11-03 | 2020-11-17 | 325412 | 8507773375!ADENOVIRUS TYPE 4 A |
| SPE2DP21F0373 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $271.49K | 2020-11-03 | 2020-11-17 | 325412 | 8507773293!ADENOVIRUS TYPE 4 A |
| SPE2DP21F0137 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $271.49K | 2020-10-19 | 2020-10-27 | 325412 | 8507719496!ADENOVIRUS TYPE 4 A |
| SPE2DP20F6741 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $271.49K | 2020-08-19 | 2020-08-25 | 325412 | 8507594798!ADENOVIRUS TYPE 4 A |
| SPE2DP20F6218 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $271.49K | 2020-07-22 | 2020-07-28 | 325412 | 8507538041!ADENOVIRUS TYPE 4 A |
| SPE2DP20F6212 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $271.49K | 2020-07-22 | 2020-07-28 | 325412 | 8507538015!ADENOVIRUS TYPE 4 A |
| SPE2DP20F5516 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $271.49K | 2020-06-17 | 2020-06-23 | 325412 | 8507472370!ADENOVIRUS TYPE 4 A |
| SPE2DP20F5515 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $271.49K | 2020-06-17 | 2020-06-23 | 325412 | 8507472349!ADENOVIRUS TYPE 4 A |
| SPE2DP20F5513 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $271.49K | 2020-06-17 | 2020-06-23 | 325412 | 8507472347!ADENOVIRUS TYPE 4 A |